As all the conditions precedent have been met, Baikowski® hereby confirms its acquisition of Mathym SAS, a company with which it commenced negotiations in July 2019.
Mathym is an innovative company operating in the area of nanomaterials and specialising in the development, manufacture and commercialisation of nanodispersions. Its products are notably used in the biomedical (dental and orthopaedic) sectors, as well as for ceramic, surface coating and 3D printing applications, where they contribute to providing or reinforcing critical properties (such as radio-opacity, refractive index or durability) of composite materials. The company, founded in 2013, currently employs 10 persons within its R&D, production, QHSE and support functions.
For Benoît Grenot, Baikowski®’s CEO:
“This first acquisition, just a few months after our listing with Euronext Growth, illustrates our determination to provide Baikowski® with new impetus. The transaction allows us to extend our know-how by integrating a talented team and provides the perspective of new markets, new advanced technological applications and a new product platform complementing Baikowski®’s existing product range”.
For Julien Alberici, Mathym®’s CEO:
“Our entire team is very happy to be joining up with Baikowski®. Our partnership will enable Mathym® to contribute its unique know-how with regard to the manufacture of innovative nanodispersions. The transaction will also provide Mathym®’s historical products the benefit of Baikowski®’s sales network worldwide and more particularly in Japan and the USA”.
Download our press release : BAIKOWSKI_Acquisition_Mathym_SAS_EN